Predicting vision outcomes in eye surface disease
Part of Eyes & vision clinical trials.
This study looks at people with diseases of the eye surface (the clear front part of the eye) to find out which factors predict how well their vision will be after treatment. By joining, you help researchers learn more about these conditions and what may affect visual recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or older.
- Have a confirmed diagnosis of a disease affecting the surface of your eye, such as dry eye, corneal inflammation, or corneal damage.
- Be able to have your vision measured with a standard eye chart and prescription lens test.
- Be willing to come back for follow-up visits and complete all study procedures.
- Not have had eye surgery within the past 3 months.
- Not have other eye conditions (like macular degeneration or glaucoma) that could affect your vision separately from your eye surface disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This observational study follows patients with limbal stem cell deficiency (a condition affecting cells at the edge of the cornea that help maintain healthy eye surface) to understand how their vision changes over time. Researchers will track your eye health without giving you new treatment.
This trial studies people whose eye surface problems are caused by an inherited (genetic) condition. It aims to better understand how specific genetic changes relate to symptoms, which may guide more personalized care.
This study tests whether a special “Brillouin” microscope scan can spot corneal ectasia and related cornea conditions. It may help doctors diagnose problems earlier and better sort out who needs closer eye care.
This study tests whether a special eye scan called OCT can better identify causes of irregular cornea shape. Results may help doctors sort out different cornea problems so treatment choices, like certain procedures, can be more targeted.
This study looks at how glaucoma and its treatments affect the surface of the eye and proteins in tears. It may help find better ways to manage eye health in people with glaucoma.
This study is building a detailed database of images and information from people with various eye diseases, especially those involving inflammation or swelling. Researchers will use advanced cameras and tests to better understand these conditions and potentially improve treatments.
Hear when a new Neurotrophic Keratopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.